800
Participants
Start Date
December 7, 2023
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2029
Abatacept
Injection: 125 mg/mL of a clear to slightly opalescent, colorless to pale-yellow solution in a single-dose prefilled ClickJect autoinjector
Standard of Care at US Transplant Centers
Control group, remaining on SOC (Tacrolimus/ Mycophenolic Acid (MPA)/ Prednisone (Pred))
RECRUITING
University of Pittsburgh Medical Center: Transplantation, Pittsburgh
RECRUITING
University of Pennsylvania Medical Center: Transplantation, Philadelphia
RECRUITING
Johns Hopkins Hospital:Transplantation, Baltimore
RECRUITING
University of Virginia Health System: Transplantation, Charlottesville
RECRUITING
Duke University Medical Center: Transplantation, Durham
RECRUITING
University of Alabama School of Medicine: Transplantation, Birmingham
NOT_YET_RECRUITING
Cleveland Clinic Foundation: Transplantation, Cleveland
NOT_YET_RECRUITING
University of Wisconsin School of Medicine and Public Health: Transplantation, Madison
RECRUITING
Mayo Clinic Rochester: Transplantation, Rochester
RECRUITING
Washington University School of Medicine in St. Louis, St Louis
RECRUITING
University of Nebraska Medical Center: Transplantation, Omaha
RECRUITING
Cedars Sinai Medical Center: Transplantation, Los Angeles
RECRUITING
Ronald Reagan UCLA Medical Center: Transplantation, Los Angeles
RECRUITING
Yale University, School of Medicine: Transplantation, New Haven
RECRUITING
Massachusetts General Hospital: Transplantation, Boston
National Institute of Allergy and Infectious Diseases (NIAID)
NIH